NCT03318939 · Interventional trial
Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
Overall registry status Terminated
Phase 2
Conditions NSCLC
Delaware Valley sites
- CTCA - Eastern Regional Medical Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory